Danaher Corp (DHR.PR.A) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Danaher Corp (DHR.PR.A:NYSE), powered by AI.

Current Price
$1841.01
Sector
Healthcare
What is the Danaher Corp stock price forecast?

Danaher Corp is currently trading at $1841.01. View real-time AI analysis on Alpha Lenz.

What is Danaher Corp insider trading activity?

View the latest insider trading data for Danaher Corp on Alpha Lenz.

What is Danaher Corp's P/E ratio?

View Danaher Corp's valuation metrics on Alpha Lenz.

Danaher Corp

$1.84K
NYSEDHR.PR.A
Ask about Danaher Corp's future dividend policy...
Alpha Chat Insight

Danaher Corp's ROE is 22.0%. Explore profitability and growth together.

Ask for details

Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

CEOMr. Rainer M. Blair
SectorHealthcare
IndustryDiagnostics & Research
Employees78,000

Company Statistics

(FY 2021)

Profile

Market CapN/A
Revenue$29.45B
Shares Out0.00
Employees78,000

Margins

Gross60.95%
EBITDA32.89%
Operating25.35%
Pre-Tax25.80%
Net21.84%

Valuation

P/EN/A
P/BN/A
EV/SalesN/A
EV/EBITDAN/A
P/FCFN/A

Growth (CAGR)

Rev 3Yr13.97%
Rev 5YrN/A
Op Inc 3Yr29.92%
Op Inc 5YrN/A
Net Inc 3Yr34.38%
Net Inc 5YrN/A

Returns

ROA39.80%
ROE21.96%
ROIC11.94%

Financial Health

Cash & Cash Equivalents$2.59B
Net Debt$31.61B
Debt/Equity107.52%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Danaher Corp (Healthcare) Stock Forecast & Analysis $1841.01 | Alpha Lenz